Kosasa Thomas
Known title: DirectorCIK: 0001989846
Kosasa Thomas's purchase track record
How the stock did after each of Kosasa Thomas's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 9 since April 21, 2025
Stock higher 6 months later
60%
3 months: 75%
Median 6-month return
+18.6%
3 months: +26.5%
Beat the S&P 500
60%
median +12.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 7/30/2026 | ONMD | $1000K | pending | pending | — |
| 6/12/2026 | ONMD | $100K | +20.0% | pending | — |
| 5/18/2026 | ONMD | $250K | -27.9% | pending | — |
| 4/23/2026 | ONMD | $250K | -32.3% | pending | — |
| 2/6/2026 | ONMD | $500K | +39.7% | -14.4% | +11.9% |
| 9/24/2025 | ONMD | $6K | +33.0% | -13.4% | -0.7% |
| 8/29/2025 | ONMD | $500K | +115.1% | +18.6% | +6.5% |
| 6/16/2025 | ONMD | $521K | +124.8% | +220.4% | +13.0% |
| 4/21/2025 | ONMD | $23K | +18.9% | +524.4% | +30.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ONMD | ▲ Buy | Open Market | 1,449,275 | $1000K | 7/30/2026 | View on chart |
| ONMD | ▲ Buy | Open Market | 158,730 | $100K | 6/12/2026 | View on chart |
| ONMD | ▲ Buy | Open Market | 268,817 | $250K | 5/18/2026 | View on chart |
| ONMD | ▲ Buy | Open Market | 280,898 | $250K | 4/23/2026 | View on chart |
| ONMD | ▲ Buy | Open Market | 595,238 | $500K | 2/6/2026 | View on chart |
| ONMD | ▲ Buy | Grant | 45,000 | $0 | 11/26/2025 | View on chart |
| ONMD | ▲ Buy | Open Market | 6,000 | $6K | 9/24/2025 | View on chart |
| ONMD | ▲ Buy | Open Market | 581,395 | $500K | 8/29/2025 | View on chart |
| ONMD | ▲ Buy | Open Market | 1,190,476 | $500K | 6/20/2025 | View on chart |
| ONMD | ▼ Sell | Other | 2,865,016 | $2.0M | 6/19/2025 | View on chart |
| ONMD | ▼ Sell | Other | 2,123,424 | $1.6M | 6/19/2025 | View on chart |
| ONMD | ▼ Sell | Other | 493,056 | $562K | 6/17/2025 | View on chart |
| ONMD | ▲ Buy | Open Market | 55,000 | $21K | 6/16/2025 | View on chart |
| ONMD | ▲ Buy | Open Market | 47,000 | $23K | 4/21/2025 | View on chart |
| ONMD | ▲ Buy | Grant | 45,000 | $0 | 1/19/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
ONMD Announces Multiyear Data Deal and 1-for-10 Reverse Split
OneMedNet signed a seven‑figure, multiyear agreement to supply derivative data to a partner. The company also announced a 1‑for‑10 reverse stock split effective September 29, 2026. With the share price near the top of its 52‑week range and an RSI above 96, the news highlights both a new revenue stream and a corporate action that may affect liquidity.
ONMD Announces Multiyear Data Deal and 1-for-10 Reverse Split. OneMedNet signed a seven‑figure, multiyear agreement to supply derivative data to a partner. The company also announced a 1‑for‑10 reverse stock split effective September 29, 2026. With the share price near the top of its 52‑week range and an RSI above 96, the news highlights both a new revenue stream and a corporate action that may affect liquidity.